Julie Ann Postai, APRN in Fort Scott, KS - Clinical Nurse Specialist

Julie Ann Postai, APRN is a Clinical Nurse Specialist - Gerontology based in Fort Scott, Kansas. Julie Ann Postai is licensed to practice in Kansas (license number 74748) and her current practice location is 1995 Locust Rd, Fort Scott, Kansas. She can be reached at her office (for appointments etc.) via phone at (660) 200-6533.

NPI number for Julie Ann Postai is 1619523057 and her current mailing address is 1995 Locust Rd, Fort Scott, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1619523057.

Contact Information

	Julie Ann Postai, APRN
	1995 Locust Rd, Fort Scott, KS 66701-7703
	(660) 200-6533
	Not Available

Provider's Profile

Full Name	Julie Ann Postai
Gender	Female
Speciality	Clinical Nurse Specialist - Gerontology
Location	1995 Locust Rd, Fort Scott, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1619523057
Provider Enumeration Date: 08/12/2019
Last Update Date: 08/12/2019

Medical Identifiers

Medical identifiers for Julie Ann Postai such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1619523057	NPI	-	NPPES
4157	Other		OTHER

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364SG0600X	Clinical Nurse Specialist - Gerontology	74748 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Julie Ann Postai is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Julie Ann Postai, APRN 1995 Locust Rd, Fort Scott, KS 66701-7703 Ph: (660) 200-6533	Julie Ann Postai, APRN 1995 Locust Rd, Fort Scott, KS 66701-7703 Ph: (660) 200-6533

News Archive

UK charity expects two million people to be diagnosed with cancer during next five years

Cancer Research UK expects around two million people to be diagnosed with cancer in the UK during the length of the next parliament according to new figures released today (Wednesday).

Physicians need to utilize best practices to treat HAE patients in emergency settings

Hereditary Angioedema (HAE) is an autosomal dominant disease causing acute attacks of intense edema. These attacks can result in life-threatening complications, including asphyxiation.

FDA provides feedback on the pending NDA for EXALGO tablets

CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).

New diagnostic test could help health officials monitor, prevent spread of H7N9 virus

Breaking research appearing online today in Clinical Chemistry, the journal of AACC, demonstrates that a recently developed diagnostic test can detect the new strain of influenza (H7N9) currently causing an outbreak in China.

SARS-CoV-2 spike protein triggers cell signaling pathways in lung vascular cells

A new study published on the preprint server bioRxiv in October 2020 shows that vascular cells in the lung tissue begin to secrete signaling growth factors when exposed to just the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), without the rest of the viral components.

Julie Ann Postai, APRN - Clinical Nurse Specialist in Fort Scott, KS